findmyKOL

Lorriana Leard, MD

Basic profile

University of California, San Francisco

ORCIDNPI
RegionSan Francisco, CA · WestSpecialtyPulmonary DiseaseFocusRespiratory
ActivityNot yet indexedfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Lorriana Leard is a Respiratory physician affiliated with University of California, San Francisco. OpenAlex indexes 138 publications with 4,722 citations (h-index 33).

Overview

Scholarship

indexed output and impact (OpenAlex)
138publications

Distinct works indexed by OpenAlex, matched via ORCID.

4,722citations

Total citations across indexed works.

33h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    58.8%
    Macrolide Antimicrobial20.3%
    Azithromycin100%
    Part D39 patients
    Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor10.5%
    Valganciclovir Hcl100%
    Part D25 patients

    + 3 more classes in this area

  • Metabolism & gastrointestinal

    18.8%
    Corticosteroid12%
    Prednisone100%
    Part D32 patients
    Proton pump inhibitor4.8%
    Omeprazole100%
    Part D13 patients

    + 1 more class in this area

  • Cancer & immunology

    16.7%
    Calcineurin inhibitor10.3%
    Tacrolimus100%
    Part D19 patients
    Kinase inhibitor6.3%
    Ofev53%Everolimus47%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”